fda compounding semaglutide warning 2025 october Drug compounders sue over declaration ending Wegovy shortage Compounded "semaglutide" is not FDA-approved

While dramatic online transformations often attract attention, realistic expectations are important

GLP-1 therapy can produce weight loss faster than intended in some individuals

Although substantial efforts have been made to improve clinical outcomes, existing therapeutic strategies demonstrate limited efficacy

Lifestyle, sleep, communication, and mental health can be equally powerful in improving libido and confidence

10.1536/ihj.16-19227396561 218 Taufiq F, Li P, Miake J, et al

Rare Diseases - Glutathione Synthase Deficiency Glutathione synthase deficiency, or proglutamicaciduria, is the most severe form of glutathione deficiency